Dr. Brian Steingo, MD

Dr. Steingo practices at Neuroscience Consultants in Boca Raton, Florida.

Dr. Steingo's NPI, 1417907163, was assigned on May 12, 2006. Dr. Steingo graduated from University of the Witwatersrand in 1971. Dr. Steingo holds Florida license ME0036908.

Dr. Steingo's primary practice is Neuroscience Consultants, at 9970 Central Park N Blvd, Boca Raton, FL 33428 in Palm Beach County. The practice phone is (786) 924-1311.

Dr. Steingo's primary practice is Neuroscience Consultants in Boca Raton, Florida. The medical group on file is First Choice Neurology. Dmand AI also links Dr. Steingo to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Steingo practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Steingo's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Steingo is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Steingo's licenses on file in 3 states: Florida, Texas and South Carolina.

Dmand AI lists fibromyalgia and chronic pain, migraine and chronic headache, multiple sclerosis, neck pain and spine problems, neuropathy and thoracic spine disorders among the conditions Dr. Steingo treats.

CMS data shows 524 Medicare services from Dr. Steingo across 4 procedure codes in 2024, for 182 Medicare patients. Medicare paid $34,639 for them. Every service was in an office.

CMS counts 182 Medicare patients who saw Dr. Steingo in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high cholesterol, and 58% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Steingo's median patient age at 59, with 75% women.

In 2024, Dr. Steingo wrote 1,955 Medicare Part D claims for 194 patients. 75% of them were for generic drugs. CMS names the drug for 1,643 of them, across 44 drugs with 11 or more claims each, at $3,896,366 in total drug cost. In 2023, CMS named 2,248 claims across 54 drugs.

Dr. Steingo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Steingo as offering telehealth.

Dmand AI links 10 papers to Dr. Steingo, published from 2012 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Immunologic Factors and Multiple Sclerosis, Relapsing-Remitting. Dr. Steingo's most frequent co-authors are Ann Doan Bass, MD, Regina R. Berkovich, MD and David Harris Margolin, MD, PhD.

Dmand AI links Dr. Steingo to 5 clinical trials. Conditions studied include Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting and Multiple Sclerosis, Chronic Progressive. Genzyme, a Sanofi Company sponsors the most, 2. Open Payments lists research payments to Dr. Steingo that name 3 trials.

CMS Open Payments shows 3,427 general payments to Dr. Steingo from 61 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. Sanofi and Genzyme US Companies paid the most, $725,822. It also lists 78 research payments totaling $48,567 from 2016 to 2025, naming 3 clinical trials.

Dmand AI lists 1 award for Dr. Steingo, most recently CMS Stage 1 EHR in 2013.

Dr. Steingo graduated from University of the Witwatersrand in 1971. Dr. Steingo is a member of AAN.

Dr. Steingo is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.